Subject:Commune 47 File:017 Date: 802-03-01 Author:Commissar Karelin, Agency Nine
High Chancellor,
I wish to update you on the progress of the ‘Commune 47’ project. Your patience and forbearance have paid off; it is with relief I can say that this project is ready to commence.
The habitation silos are ready to accept their new inhabitants and I shall imminently be signing off the orders for the volunteer’s relocation. Three thousand beds have been prepared in the combination of apartment configurations specified by Agency Thirteen. Initially, this proved to be a challenge when accounting for the need to incorporate the necessary processing facilities, project staff living quarters and observation platforms. This caused the project’s delay in readiness passed our established deadline.
Delays for which I am still apologetic for, High Chancellor. It was the gifted officials of the Agency's engineering corp that enabled the project to continue after a breakthrough in adjusting the silo architectural design and the adoption of sound-cancelling composites in partitions. This was critical for maximising the usage of space whilst keeping habitants from detecting project staff. Truly, it is through the collective might of our institutions that we succeed in all things.
With staff briefed and the facsimile of routine habitat life prepared, the project awaits only the arrival of volunteers, the required shipments of cardamine for phase one, and your signature, High Chancellor.
I eagerly await to begin the experiment with your blessing.
Subject: Phase One progress report
File: 041
Date: 802-09-27
Author: Dr. Gabriela Martez, Agency Nine. Project Lead.
I am pleased to report that Forty-Seven has shown great progress in the preliminary phase. Control groups Forty-Three and Forty-Four are also nearing the end of their preliminary phase, and as such experimentation may begin imminently.
The sample population was relocated into the habitat swiftly. Re-culturisation was carried out before any implementation of experimental method. In order to ensure the ongoing commitment of the newly settled residents, of course. The isolation phase, phase zero, proved taxing on the staff's mentality, but we understand it's purpose. I admit I...
::: Data Unavailable :::
... initial attempts of the processing of cardamine into various intake forms to began four months ago. The first batches of product have been prepared and are ready for administration. Subjects have been put through a selection process and divided into four groups.
Firstly, of course, is an internal control group comprising of two thousand residents. These residents are to serve as a benchmark group against which to measure the impact of cardamine usage in the other groups.
A second group, comprising of three hundred residents, shall be administered cardamine via breather mask. Gathered intelligence on those supplying cardamine into House space suggests this is a common form of the drugs administration.
A third group, comprising of another three hundred residents, shall be administered cardamine via a tobacco/cardamine mix that imitates the common cigarette. This method of intake may be easier for subjects to incorporate into their daily routine, and the effects of this form of intake are to be monitored closely.
A fourth group, comprising of another three hundred residents, shall be administered cardamine in compressed liquid state. A hypothetical application, it is thought that if a stable compound in a measurable dose the human body can endure can be determined, this may prove the most potent in delivering the hypothesised mental acuity that this substance is rumoured to provide.
The remaining residents, the last one hundred, were unfortunately lost during re-culturisation. A heavy cost, but with these preliminary preparations concluded I am eager to begin the experiment in earnest.
Subject: Phase Two - progress report
File: 095
Date: 803-02-13
Author: Dr. Gabriela Martez, Agency Nine. Project Lead.
The last of trial group four expired in the evening last cycle. This loss is regrettable; without the group's initial subjects there will need to be a cessation into the data being collected on the application of liquid cardamine. A requisition request for three hundred more subjects has been made. I harbour doubts as to how more subjects could be introduced into the habitat without breaking isolation protocols. One must try, however.
Perhaps this is for the best. Subjects administered liquid cardamine have consistently experienced extreme maleffects, often leading to swift transitions into psychosis. They speak of other worlds. Impossible structures, alien horizons, et cetera, before burning out. Strange... it occurs to me now how similar their rantings are. I shall arrange a review of the autopsies to evaluate for any commonalities in brain malformity.
As for the other experimental groups, results have been markedly more positive. Subjects within trial group two exhibitied a meteoric rise in productivity. Initially. Full of vitality and vigour, medical staff have extensively documented positive effects on health and wellbeing whilst simultaneously working longer shifts with greater output. This has been particularly true for those in the excavating and manufacturing cadres.
The cost of this boon made itself evident before long. So dependent did these subjects become to the substance that staff began to discover groups of subjects taking continual doses, hiding within the habitat and loosing themselves to the euphoric effects of the substance. I believe the term that subjects have been using is 'checking out'. On discussion, Commissar Karelin and I are agreed that intervention into this situation should not be made. We shall learn more about the longer-term effects of cardamine if we were to let the issue run it's course.
Trial group three is, perhaps, our most promising implementation of the substance. Subjects have reported elevated mood, function and productivity. Admittedly the nature of the tobcco-cardamine mix, where dosages are smaller, more drawn out and more frequent, have resulted in the magnitude of effect on subjects to be smaller. However, there have yet to be reports of any 'checking out' of trial group subjects. This is promising. If a sustainable 'high' can be facilitated then this form of intake may prove to be a more palatable and steady product to administer to the general workforce.
In light of these findings, I shall be proposing to the Commissar and the High Chancellor that we proceed into a modified phase three. Bring the internal control group into the active subject pool, place one third of those onto breather administration, and the rest onto the cardamine mix.
![[Image: zwW7lPs.png]](https://i.imgur.com/zwW7lPs.png)